- Home
- News
- Treatment & Care
- HIV Worldwide
- Living with HIV
- Preventing HIV
- Organisations
- HIV Basics
- About Us
- Recent news headlines
- New position with NAM and HATIP
- Are you translating or adapting our materials?
feedback
Give us your views on our work
Are you translating or adapting our materials?
If so, we'd love to hear from you!
During the International AIDS Conference we met delegates from all over the world who are translating or adapting our materials into numerous languages.
For example we learnt about translations of various materials, including articles from HATIP, into Nepali, Russian, Romanian, Creole, Swahili and Shona.
We'd like to collect and make available as many translations and adaptations as possible through our website, and publicise them, along with the work of the groups who have carried our those translations and adaptations.
Please get in touch with us and tell us what you are doing, so we can share these translations and adaptations as widely as possible. Please send us a pdf copy too!
We are also very interested in hearing your feedback - how did you have to adapt the material for your local setting, and what materials would be useful in the future?
Current translated materials in French: http://www.aidsmap.com/cms1176923.asp
Current translated materials in Spanish (with GTT, Spain): http://www.aidsmap.com/cms1176921.asp
Current translated materials in Portuguese (with GAT, Portugal): http://www.aidsmap.com/cms1176922.asp
Current translated materials in Russian: http://www.aidsmap.com/cms1038155.asp
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- HIV/TB epidemic in Eastern Europe a 'public health disaster'
- Low bone mineral density common in HIV-positive men
- Circumcision may protect HIV-negative gay men from syphilis
- HIV 'exposure' from bite forms basis for terrorism charge in US case
- First hint of a hepatitis C vaccine?
- Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women
- Surviving to die of something else: AIDS is a rare cause of death in old people with HIV
- New EACS guidelines address co-morbidities and diseases of age
- Small case series looks at etravirine during pregnancy
- Protease inhibitor monotherapy as a maintenance regimen: are we edging towards acceptance?